A radioimmunoassav was developed to measure calmodulin in striatum from rats treated with one dose or repeated injections of amphetamine. Chronic, but not acute, amphetamine treatment resulted in a significant increase in total calmodulin levels in striatal homogenates. This effect may be linked to the behavioral sensitization which develops after chronic amphetamine treatments.
A radioimmunoassav was developed to measure calmodulin in striatum from rats treated with one dose or repeated injections of amphetamine. Chronic, but not acute, amphetamine treatment resulted in a significant increase in total calmodulin levels in striatal homogenates. This effect may be linked to the behavioral sensitization which develops after chronic amphetamine treatments.
When rats are administered a single dose or repeated injections of amphetamine (AMPH), they exhibit a marked behavioral potentiation to subsequent challenges with AMPH which persists several weeks after the initial exposure to the drug la. This pharmacological sensitization is correlated with an increase in the amount of dopamine which is released from striatal tissue in vitro in response to AMPH infusion 91). The molecular events underlying these changes are unknown. The present study was designed to explore the possible involvement of the calcium binding protein, calmodulin (CAM), which affects a number of critical enzyme activities in the CNS, including calcium-dependent adenylate cyclase, phosphodiesterase, and protein kinase activities ~°. This neuromodulator protein is particularly enriched in synaptic fractions of the brain, where it is associated with the nuclear matrix, cytosol, vesicles, and postsynaptic density R°. CaM appears to be involved in the synthesis and release of many neurotransmitters, as well as other possible cell functions s. CaM is also abundant in striatum 19, where it has a demonstrated role in modulating dopaminergic activity through the dopamine-sensitive adenylate cyclase system ~7. Treatments which up-or down-regulate dopaminergic activity result in a redistribution of CaM between membrane and soluble subcellular fractions 6'7. Therefore, CaM may have an important role in the regulation of dopaminergic neurotransmission in the nigrostriatal pathway, and in the behavioral changes due to manipulations of this system. We report here that a regimen of AMPH which results in behavioral sensitization also produces a significant increase in CaM levels in striatal homogenates.
Polyclonal antibodies against CaM were prepared in a sheep that was first immunized with performic acid-oxidized CaM 17, then boosted with injections of native protein, according to the procedure described in Dedman et al 4. Upon bleeding, serum for the radioimmunoassay described below is obtained by allowing the blood to clot, followed by centrifugation at 6000 g for 20 min at 4 °C. This serum is then stored at -20 °C until it is thawed and diluted for use in the assay. Calmodulin from rat testes was purified by the method of Dedman et al 3, and was radio-iodinated, or used for the standards in the radioimmunoassay described below. Lyophilized parvalbumin was obtained from Sigma Chemical Company.
Female, Holtzman rats (225-250 g) were injected (i.p.) with either 2.5 mg/kg AMPH or an equal volume of saline once daily for 5 days. Ten days after the
